
Show Notes
The treatment of soft tissue sarcomas is a highly specialised area. The first effective chemotherapy agent against sarcomas was only identified in the 1960s and benefits of adjuvant radiotherapy treatment began in the 1970s. We continue to learn as new agents become available and tailor treatments to each patient. This is the story of Soft Tissue Sarcoma (Part 2). Here is the link to Part 1. Useful links: Australia and New Zealand Sarcoma Association: https://sarcoma.org.au/ Find a sarcoma specialist: https://sarcoma.org.au/pages/about-sarcoma/find-a-sarcoma-specialist Sarcoma guidelines: https://sarcoma.org.au/pages/sarcoma-guidelines Seeking a second opinion: https://sarcoma.org.au/pages/about-sarcoma/seeking-second-opinion Useful patient information: https://sarcoma.org.au/pages/about-sarcoma/patient-and-carer-sarcoma-information Article from the RCPA about reviewing soft tissue tumours and obtaining second opinions: https://pubmed.ncbi.nlm.nih.gov/41390329/ Our Special Guests: Professor Peter Grimison who is a medical oncologist at Chris O’Brien Lifehouse and clinical professor at University of Sydney Associate Professor Stephen Thompson is a radiation oncologist at Prince of Wales hospital and conjoint associate professor at the University of New South Wales The treatment of soft tissue sarcomas is a highly specialised area. The first effective chemotherapy agent against sarcomas was only identified in the 1960s and benefits of adjuvant radiotherapy treatment began in the 1970s. We continue to learn as new agents become available and tailor treatments to each patient. This is the story of Soft Tissue Sarcoma (Part 2). Here is the link to Part 1. Useful links: Australia and New Zealand Sarcoma Association: https://sarcoma.org.au/ Find a sarcoma specialist: https://sarcoma.org.au/pages/about-sarcoma/find-a-sarcoma-specialist Sarcoma guidelines: https://sarcoma.org.au/pages/sarcoma-guidelines Seeking a second opinion: https://sarcoma.org.au/pages/about-sarcoma/seeking-second-opinion Useful patient information: https://sarcoma.org.au/pages/about-sarcoma/patient-and-carer-sarcoma-information Article from the RCPA about reviewing soft tissue tumours and obtaining second opinions: https://pubmed.ncbi.nlm.nih.gov/41390329/ Our Special Guests: Professor Peter Grimison who is a medical oncologist at Chris O’Brien Lifehouse and clinical professor at University of Sydney Associate Professor Stephen Thompson is a radiation oncologist at Prince of Wales hospital and conjoint associate professor at the University of New South Wales Listen: This Medical Life podcast is available on all podcasting services and Spotify. Members of the RACGP are able to log the hours as CPD (Education) that they listen to the episodes under self record via Quick log. We invite you to help support us on our donation page. See omnystudio.com/listener for privacy information.
More from This Medical Life
Pleomorphic adenoma is the most common parotid tumour. ENT surgeon Dr Rowan Valentine covers assessment, red flags and surgery in Episode 112.
Professor Ken Sikaris explains the 2026 Australian prostate cancer early detection guidelines: new PSA thresholds by age, MRI's role and why free PSA is gone.
A patient with 200 sleep attacks a day helped define narcolepsy in 1880. Di Spillaine and Professor Robert Adams on symptoms, diagnosis and treatment today.
Dr Louise Stone on a decade of research into sexual harassment in medicine, why it persists, and what actually helps a colleague or trainee.
A 1901 case first identified Alzheimer's disease. Dr Daniel Clarke and Dr Gemma Daley on today's presentation, workup and new blood biomarker tests.